Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 19, Issue 2

March-April 2022

In this Issue

Ask the Hematologists
Clinical Trials Corner
Diffusion
Headlines from Washington
Image Challenge
In Memoriam
Mini Review
President's Column
Profile

Ask the Hematologists

When Is a Needle Not Enough? Exploring the Limits of Cytology and Core Biopsies

Kristen M. O'Dwyer, MD,Richard Burack, MD, PhD

View Articletitled, When Is a Needle Not Enough? Exploring the Limits of Cytology and Core Biopsies

Clinical Trials Corner

Defining Optimal Management of Patients With Intermediate-risk Pulmonary Emboli

Damon Houghton, MD

View Articletitled, Defining Optimal Management of Patients With Intermediate-risk Pulmonary Emboli

Survival of the Fittest: Hypomethylating Agent/BCL-2 Inhibitor Combination Versus Intensive Chemotherapy As Frontline Treatment for Acute Myeloid Leukemia

Michael J. Hochman, MD,Robert P. Hasserjian, MD

View Articletitled, Survival of the Fittest: Hypomethylating Agent/BCL-2 Inhibitor Combination Versus Intensive Chemotherapy As Frontline Treatment for Acute Myeloid Leukemia

Diffusion

Subsegmental Pulmonary Embolism: To Treat or Not to Treat?

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Subsegmental Pulmonary Embolism: To Treat or Not to Treat?

Primary Plasma Cell Leukemia Re(de)fined

Carlyn Rose, Tan, MD,Saad Usmani, MD, MBA, FACP

View Articletitled, Primary Plasma Cell Leukemia Re(de)fined

Navigating the Treatment Landscape of Advanced Follicular Lymphoma: Should You Consider a CAR, and Which Model?

Loretta J. Nastoupil, MD

View Articletitled, Navigating the Treatment Landscape of Advanced Follicular Lymphoma: Should You Consider a CAR, and Which Model?

Inhibiting the Polymerization of Sickle Hemoglobin: It's Complicated

David C. Rees, MA, MBBS

View Articletitled, Inhibiting the Polymerization of Sickle Hemoglobin: It's Complicated

Back to HiDAC: Administering the Optimal Treatment for Children With Down Syndrome and Acute Myeloid Leukemia

Kristen M. O’Dwyer, MD

View Articletitled, Back to HiDAC: Administering the Optimal Treatment for Children With Down Syndrome and Acute Myeloid Leukemia

Modelling Myelofibrosis in Vivo: Success With NSG-S

Ruggiero Norfo, PhD,Bethan Psaila, MD, PhD

View Articletitled, Modelling Myelofibrosis <em>in Vivo</em>: Success With NSG-S

STAMPing on BCR-ABL1: Asciminib Approved for Chronic Myeloid Leukemia

Christine M. McMahon, MD

View Articletitled, STAMPing on BCR-ABL1: Asciminib Approved for Chronic Myeloid Leukemia

New Tricks and Old Dogs: Will the Addition of Venetoclax to Conventional Multidrug Chemotherapy Decrease Relapse Risk for Younger Adults With Newly Diagnosed AML?

Grace Egan, MD,Sarah K. Tasian, MD

View Articletitled, New Tricks and Old Dogs: Will the Addition of Venetoclax to Conventional Multidrug Chemotherapy Decrease Relapse Risk for Younger Adults With Newly Diagnosed AML?

Headlines from Washington

ASH Supported Sickle Cell Legislation Introduced in Congress

ASH Staff

View Articletitled, ASH Supported Sickle Cell Legislation Introduced in Congress

Image Challenge

ALK-Inhibitor–Induced Spheroacanthocytosis

Priscilla Yeung, MD, PhD,Fei Fei, MD,Sebastian Fernandez-Pol, MD, PhD

View Articletitled, ALK-Inhibitor–Induced Spheroacanthocytosis

In Memoriam

In Memoriam: Hal E. Broxmeyer, PhD (1944-2021)

Joanne Kurtzberg, MD

View Articletitled, In Memoriam: Hal E. Broxmeyer, PhD (1944-2021)

Mini Review

Autoimmune (Acquired) Hemophilia: Updates in Diagnosis and Therapy

Meera Sridharan, MD, PhD,Rajiv K. Pruthi, MBBS

View Articletitled, Autoimmune (Acquired) Hemophilia: Updates in Diagnosis and Therapy

President's Column

The Ripple Effect Is Real: ASH Advocacy in 2022

Jane N. Winter, MD

View Articletitled, The Ripple Effect Is Real: ASH Advocacy in 2022

Profile

“And for My Next Act…”: An Interview With Dr. Manfred Steiner

Laura C. Michaelis, MD

View Articletitled, “And for My Next Act…”: An Interview With Dr. Manfred Steiner

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologists

When Is a Needle Not Enough? Exploring the Limits of Cytology and Core Biopsies

Clinical Trials Corner

Defining Optimal Management of Patients With Intermediate-risk Pulmonary Emboli

Survival of the Fittest: Hypomethylating Agent/BCL-2 Inhibitor Combination Versus Intensive Chemotherapy As Frontline Treatment for Acute Myeloid Leukemia

Diffusion

Subsegmental Pulmonary Embolism: To Treat or Not to Treat?

Primary Plasma Cell Leukemia Re(de)fined

Navigating the Treatment Landscape of Advanced Follicular Lymphoma: Should You Consider a CAR, and Which Model?

Inhibiting the Polymerization of Sickle Hemoglobin: It's Complicated

Back to HiDAC: Administering the Optimal Treatment for Children With Down Syndrome and Acute Myeloid Leukemia

Modelling Myelofibrosis in Vivo: Success With NSG-S

STAMPing on BCR-ABL1: Asciminib Approved for Chronic Myeloid Leukemia

New Tricks and Old Dogs: Will the Addition of Venetoclax to Conventional Multidrug Chemotherapy Decrease Relapse Risk for Younger Adults With Newly Diagnosed AML?

Headlines from Washington

ASH Supported Sickle Cell Legislation Introduced in Congress

Image Challenge

ALK-Inhibitor–Induced Spheroacanthocytosis

In Memoriam

In Memoriam: Hal E. Broxmeyer, PhD (1944-2021)

Mini Review

Autoimmune (Acquired) Hemophilia: Updates in Diagnosis and Therapy

President's Column

The Ripple Effect Is Real: ASH Advocacy in 2022

Profile

“And for My Next Act…”: An Interview With Dr. Manfred Steiner

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologists

Clinical Trials Corner

Diffusion

Headlines from Washington

Image Challenge

In Memoriam

Mini Review

President's Column

Profile

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only